Macrolide resistance of mycoplasma pneumoniae, South Korea, 2000-2011

Emerging Infectious Diseases

Volumn 19, Issue 8, 2013, Pages 1281-1284

  Hong, Ki Bae ^a   Choi, Eun Hwa ^b   Lee, Hoan Jong ^b   Lee, Seong Yeon ^a   Cho, Eun Young ^a   Choi, Jae Hong ^a   Kang, Hyun Mi ^a   Lee, Jina ^c   Ahn, Young Min ^d   Kang, Yeon Ho ^e   Lee, Joon Ho ^f  

^a Seoul National University Hospital   (South Korea)

^b Seoul National University College of Medicine   (South Korea)

^c Seoul National University Bundang Hospital   (South Korea)

^d Eulji General Hospital   (South Korea)

^e Korea Centers for Disease Control and Prevention   (South Korea)

^f Kangwon National University   (South Korea)

Author keywords

[No Author keywords available]

Indexed keywords

ADHESIN; AZITHROMYCIN; CIPROFLOXACIN; CLARITHROMYCIN; DOXYCYCLINE; ERYTHROMYCIN; JOSAMYCIN; LEVOFLOXACIN; MACROLIDE; MOXIFLOXACIN; RNA 23S; ROXITHROMYCIN; TETRACYCLINE;

ADOLESCENT; ADULT; ANTIBIOTIC RESISTANCE; ARTICLE; BACTERIUM DETECTION; CHILD; GENE MUTATION; GENETIC VARIABILITY; GEOGRAPHIC DISTRIBUTION; HUMAN; INFANT; MINIMUM INHIBITORY CONCENTRATION; MYCOPLASMA PNEUMONIA; POLYMERASE CHAIN REACTION; PRESCHOOL CHILD; PREVALENCE; SOUTH KOREA;

MACROLIDE; MYCOPLASMA PNEUMONIAE; PNEUMONIA; RESISTANCE; RESPIRATORY INFECTIONS; SOUTH KOREA; TUBERCULOSIS AND OTHER MYCOBACTERIA;

ADOLESCENT; ANTI-BACTERIAL AGENTS; CHILD; CHILD, PRESCHOOL; DNA MUTATIONAL ANALYSIS; DRUG RESISTANCE, BACTERIAL; EPIDEMICS; FLUOROQUINOLONES; HUMANS; INFANT; MACROLIDES; MICROBIAL SENSITIVITY TESTS; MUTATION; MYCOPLASMA PNEUMONIAE; PNEUMONIA, MYCOPLASMA; PREVALENCE; REPUBLIC OF KOREA; RNA, BACTERIAL; RNA, RIBOSOMAL, 23S; TETRACYCLINES;

EID: 84880754996     PISSN: 10806040     EISSN: 10806059     Source Type: Journal    
DOI: 10.3201/eid1908.121455     Document Type: Article

References (15)

1. Matsuoka M, Narita M, Okazaki N, Ohya H, Yamazaki T, Ouchi K, et al. Characterization and molecular analysis of macrolideresistant Mycoplasma pneumoniae clinical isolates obtained in Japan. Antimicrob Agents Chemother. 2004;48:4624-30. http://dx.doi.org/10.1128/AAC.48.12.4624-4630.2004
2. Atkinson TP, Balish MF, Waites KB. Epidemiology, clinical manifestations, pathogenesis and laboratory detection of Mycoplasma pneumoniae infections. FEMS Microbiol Rev. 2008;32:956-73. http://dx.doi.org/10.1111/j.1574-6976.2008.00129.x
3. Eun BW, Kim NH, Choi EH, Lee HJ. Mycoplasma pneumoniae in Korean children: the epidemiology of pneumonia over an 18-year period. J Infect. 2008;56:326-31. http://dx.doi.org/10.1016/ j.jinf.2008.02.018
4. Morozumi M, Iwata S, Hasegawa K, Chiba N, Takayanagi R, Matsubara K, et al. Increased macrolide resistance of Mycoplasma pneumoniae in pediatric patients with community-acquired pneumonia. Antimicrob Agents Chemother. 2008;52:348-50. http://dx.doi. org/10.1128/AAC.00779-07
5. Peuchant O, Menard A, Renaudin H, Morozumi M, Ubukata K, Bebear CM, et al. Increased macrolide resistance of Mycoplasma pneumoniae in France directly detected in clinical specimens by real-time PCR and melting curve analysis. J Antimicrob Chemother. 2009;64:52-8. http://dx.doi.org/10.1093/jac/dkp160
6. Xin D, Mi Z, Han X, Qin L, Li J, Wei T, et al. Molecular mechanisms of macrolide resistance in clinical isolates of Mycoplasma pneumoniae from China. Antimicrob Agents Chemother. 2009;53:2158-9. http://dx.doi.org/10.1128/AAC.01563-08
7. Dumke R, von Baum H, Luck PC, Jacobs E. Occurrence of macrolide-resistant Mycoplasma pneumoniae strains in Germany. Clin Microbiol Infect. 2010;16:613-6. http://dx.doi.org/10.1111/ j.1469-0691.2009.02968.x
8. Averbuch D, Hidalgo-Grass C, Moses AE, Engelhard D, Nir-Paz R. Macrolide resistance in Mycoplasma pneumoniae, Israel, 2010. Emerg Infect Dis. 2011;17:1079-82. http://dx.doi.org/10.3201/ eid1706.101558
9. Liu Y, Ye X, Zhang H, Xu X, Li W, Zhu D, et al. Antimicrobial susceptibility of Mycoplasma pneumoniae isolates and molecular analysis of macrolide-resistant strains from Shanghai, China. Antimicrob Agents Chemother. 2009;53:2160-2. http://dx.doi.org/10.1128/AAC.01684-08
10. Wolff BJ, Thacker WL, Schwartz SB, Winchell JM. Detection of macrolide resistance in Mycoplasma pneumoniae by real-time PCR and high-resolution melt analysis. Antimicrob Agents Chemother. 2008;52:3542-9. http://dx.doi.org/10.1128/AAC.00582-08
11. Clinical and Laboratory Standards Institute. Performance standards for antimicrobial susceptibility testing-twenty-first information supplement: approved standard M100-S 21. Wayne (PA): The Institute; 2011.
12. Okazaki N, Narita M, Yamada S, Izumikawa K, Umetsu M, Kenri T, et al. Characteristics of macrolide-resistant Mycoplasma pneumoniae strains isolated from patients and induced with erythromycin in vitro. Microbiol Immunol. 2001;45:617-20.
13. Okada T, Morozumi M, Tajima T, Hasegawa M, Sakata H, Ohnari S, et al. Rapid effectiveness of minocycline or doxycycline against macrolide-resistant Mycoplasma pneumoniae infection in a 2011 outbreak among Japanese children. Clin Infect Dis. 2012;55:1642-9. http://dx.doi.org/10.1093/cid/cis784
14. Chironna M, Sallustio A, Esposito S, Perulli M, Chinellato I, Di Bari C, et al. Emergence of macrolide-resistant strains during an outbreak of Mycoplasma pneumoniae infections in children. J Antimicrob Chemother. 2011;66:734-7. http://dx.doi.org/10.1093/jac/dkr003
15. Korean Centers for Disease Control and Prevention, Korea National Institute of Health. Korean Antimicrobial Resistance Monitoring System annual report. Chungbuk (South Korea): The Centers; 2011.